| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.4 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |